Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives.
Ferro A, Bottosso M, Dieci MV, Scagliori E, Miglietta F, Aldegheri V, Bonanno L, Caumo F, Guarneri V, Griguolo G, Pasello G. Ferro A, et al. Among authors: bottosso m. Crit Rev Oncol Hematol. 2024 Nov;203:104479. doi: 10.1016/j.critrevonc.2024.104479. Epub 2024 Aug 14. Crit Rev Oncol Hematol. 2024. PMID: 39151838 Free article. Review.
TP53-associated early breast cancer: new observations from a large cohort.
Sandoval RL, Bottosso M, Tianyu L, Polidorio N, Bychkovsky BL, Verret B, Gennari A, Cahill S, Achatz MI, Caron O, Imbert-Bouteille M, Noguès C, Mawell KN, Fortuno C, Spurdle AB, Tayob N, Andre F, Garber JE. Sandoval RL, et al. Among authors: bottosso m. J Natl Cancer Inst. 2024 Aug 1;116(8):1246-1254. doi: 10.1093/jnci/djae074. J Natl Cancer Inst. 2024. PMID: 38569880
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.
Miglietta F, Ragazzi M, Fernandes B, Griguolo G, Massa D, Girardi F, Bottosso M, Bisagni A, Zarrilli G, Porra F, Iannaccone D, Dore L, Gaudio M, Santandrea G, Fassan M, Lo Mele M, De Sanctis R, Zambelli A, Bisagni G, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: bottosso m. Clin Cancer Res. 2023 Sep 1;29(17):3429-3437. doi: 10.1158/1078-0432.CCR-23-0480. Clin Cancer Res. 2023. PMID: 37417941 Free PMC article.
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.
Miglietta F, Carraro V, Amato O, Griguolo G, Bottosso M, Munari G, Zarrilli G, Lo Mele M, Barbieri C, Dei Tos AP, Guarneri V, Dieci MV, Fassan M. Miglietta F, et al. Among authors: bottosso m. J Clin Pathol. 2024 Sep 19;77(10):690-696. doi: 10.1136/jcp-2023-208856. J Clin Pathol. 2024. PMID: 37344170 Free PMC article.
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients.
Griguolo G, Aldegheri V, Bottosso M, Pittaro A, Caumo F, Guarascio MC, Pouderoux S, Busato F, Miglietta F, Jacot W, Dieci MV, Darlix A, Guarneri V. Griguolo G, et al. Among authors: bottosso m. Int J Cancer. 2023 Sep 15;153(6):1217-1226. doi: 10.1002/ijc.34571. Epub 2023 May 27. Int J Cancer. 2023. PMID: 37243480
25 results